To our knowledge, this study is the first to demonstrate that ultrasound combined with microbubbles can enhance the efficacy of NLRP3 inflammasome inhibitors, resulting in improved renal function and reduced fibrosis in a CKD rat model. Here, NLRP3 is linked to chronic kidney disease.